{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:29:23Z","timestamp":1789223363726,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Imeglimin, a novel oral hypoglycemic agent, is known to influence mitochondrial function and glucose metabolism. This study evaluates its effects on glycemic control, mitochondrial DNA (mtDNA) copy number, and telomere dynamics in type 2 diabetes mellitus (T2DM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Type 2 diabetes mellitus patients were assigned to one of four treatment groups: (1) Imeglimin alone, (2) Imeglimin with metformin, (3) Imeglimin with other oral hypoglycemic agents, and (4) Metformin with other oral hypoglycemic agents. Clinical and metabolic parameters, mtDNA copy number, and relative telomere length were assessed at baseline and six months. Statistical analyses included paired t-tests and mixed models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included participants with a mean age of 55.6 years (57% male, BMI 28.8 kg\/m<jats:sup>2<\/jats:sup>). HbA1c significantly decreased in the Imeglimin + Other OHA (p &amp;lt; 0.001), Imeglimin + Metformin (p &amp;lt; 0.001), and Metformin + Other OHA (p &amp;lt; 0.001) groups, with a smaller but significant decrease in the Imeglimin monotherapy group (p = 0.04). mtDNA copy number increased significantly in the Imeglimin-based combination groups (p &amp;lt; 0.05) but not with monotherapy (p = 0.18). No serious adverse events were reported. Relative telomere length was only associated with age and changes in LDL-c levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Imeglimin-based combination therapy effectively improves glycemic control and mitochondrial function, while monotherapy offers limited benefits. Combination therapy may be preferable for optimizing metabolic outcomes in T2DM. No significant change in telomere length was observed during the short period of time.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1585834","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:10:34Z","timestamp":1754021434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Imeglimin on mitochondrial function in patients with type 2 diabetes mellitus: a prospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Abhishek","family":"Satheesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janardanan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakithakara Vajravelu","family":"Leela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.06.029","article-title":"Diabetes mellitus-Progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress","volume":"14","author":"Dludla","year":"2023","journal-title":"World J Diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030658","article-title":"Mitochondrial dysfunction, oxidative stress, and therapeutic strategies in diabetes, obesity, and cardiovascular disease","volume":"12","author":"Cojocaru","year":"2023","journal-title":"Antioxidants"},{"key":"B4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/1873-3468.14021","article-title":"Mitochondrial DNA copy number in human disease: the more the better","volume":"595","author":"Filograna","year":"2021","journal-title":"FEBS Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110522","article-title":"Leukocyte mitochondrial DNA copy number and cardiovascular disease: A systematic review and meta-analysis of cohort studies","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30365-X","article-title":"Diabetes, metabolic disease, and telomere length","volume":"9","author":"Cheng","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010125","article-title":"Telomere maintenance is associated with type 2 diabetes remission in response to a long-term dietary intervention without non-weight loss in patients with coronary heart disease: from the CORDIOPREV randomized controlled trial","volume":"13","author":"Ojeda-Rodriguez","year":"2024","journal-title":"Antioxidants"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae536","article-title":"The association between telomere length and diabetes mellitus: accumulated evidence from observational studies","volume":"110","author":"He","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14277","article-title":"Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes","volume":"23","author":"Hallakou-Bozec","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/biology12050726","article-title":"Glucose-lowering effects of imeglimin and its possible beneficial effects on diabetic complications","volume":"12","author":"Yanai","year":"2023","journal-title":"Biology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jphs.2024.03.004","article-title":"Imeglimin attenuates NLRP3 inflammasome activation by restoring mitochondrial functions in macrophages","volume":"155","author":"Lee","year":"2024","journal-title":"J Pharmacol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1038\/s41598-024-56769-w","article-title":"Imeglimin mitigates the accumulation of dysfunctional mitochondria to restore insulin secretion and suppress apoptosis of pancreatic \u03b2-cells from db\/db mice","volume":"14","author":"Aoyagi","year":"2024","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13111415","article-title":"Imeglimin halts liver damage by improving mitochondrial dysfunction in a nondiabetic male mouse model of metabolic dysfunction-associated steatohepatitis","volume":"13","author":"Kaji","year":"2024","journal-title":"Antioxidants"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1270-5_15","article-title":"Accurate measurement of cellular and cell-free circulating mitochondrial DNA content from human blood samples using real-time quantitative PCR","volume":"2277","author":"Rosa","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/mps3020027","article-title":"An optimised step-by-step protocol for measuring relative telomere length","volume":"3","author":"Joglekar","year":"2020","journal-title":"Methods Protoc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15151","article-title":"Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin","volume":"10","author":"Theurey","year":"2022","journal-title":"Physiol Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13220","DOI":"10.1038\/s41598-022-17657-3","article-title":"Imeglimin exerts favorable effects on pancreatic \u03b2-cells by improving morphology in mitochondria and increasing the number of insulin granules","volume":"12","author":"Sanada","year":"2022","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.70092","article-title":"Imeglimin improves hyperglycemia and hypoglycemia-induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells","author":"Kato","year":"2025","journal-title":"J Diabetes Investig"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0763","article-title":"Efficacy and safety of imeglimin monotherapy versus placebo in Japanese patients with type 2 diabetes (TIMES 1): A double-blind, randomized, placebo-controlled, parallel-group, multicenter phase 3 trial","volume":"44","author":"Dubourg","year":"2021","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14613","article-title":"Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial","volume":"24","author":"Dubourg","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00886-y","article-title":"Imeglimin does not induce clinically relevant pharmacokinetic interactions when combined with either metformin or sitagliptin in healthy subjects","volume":"59","author":"Fouqueray","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"bqad095","DOI":"10.1210\/endocr\/bqad095","article-title":"Protective effects of imeglimin and metformin combination therapy on \u03b2-cells in db\/db male mice","volume":"164","author":"Nishiyama","year":"2023","journal-title":"Endocrinology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-022-01298-w","article-title":"The effects of imeglimin on the daily glycemic profile evaluated by intermittently scanned continuous glucose monitoring: retrospective, single-center, observational study","volume":"13","author":"Oda","year":"2022","journal-title":"Diabetes Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6319","article-title":"Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients","volume":"16","author":"Al\u2212Kafaji","year":"2018","journal-title":"Exp Ther Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13242","article-title":"Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals","volume":"290","author":"Fazzini","year":"2021","journal-title":"J Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001204","article-title":"Mitochondrial DNA copy number and diabetes: the Atherosclerosis Risk in Communities (ARIC) study","volume":"8","author":"DeBarmore","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1038\/s41598-021-84132-w","article-title":"Association of mitochondrial DNA copy number with prevalent and incident type 2 diabetes in women: A population-based follow-up study","volume":"11","author":"Memon","year":"2021","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2021.06.010","article-title":"Blood mitochondrial DNA copy number: What are we counting","volume":"60","author":"Picard","year":"2021","journal-title":"Mitochondrion"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05280-5","article-title":"Impairment of platelet mitochondrial respiration in patients with chronic kidney disease with and without diabetes","author":"Mihaela-Roxana","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/nu16101404","article-title":"Fasting and glucose metabolism differentially impact peripheral inflammation in human type 2 diabetes","volume":"16","author":"Kalantar","year":"2024","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0152","article-title":"Oxidative stress and mitochondrial dysfunction associated with peripheral neuropathy in type 1 diabetes","volume":"37","author":"Eftekharpour","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1159\/000511362","article-title":"The association between antidiabetic agents and leukocyte telomere length in the novel classification of type 2 diabetes mellitus","volume":"67","author":"Huang","year":"2020","journal-title":"Gerontology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01297-w","article-title":"Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1\u03b1 pathway","volume":"56","author":"Sung","year":"2024","journal-title":"Exp Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208533","article-title":"Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes","volume":"13","author":"Garcia-Martin","year":"2018","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204293","article-title":"Telomere length and mitochondrial DNA copy number variations in patients with obesity: effect of diet-induced weight loss\u2014A pilot study","volume":"14","author":"Cancello","year":"2022","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa115","article-title":"Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors","volume":"29","author":"Baragetti","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/nu15214497","article-title":"Association between lipids, apolipoproteins and telomere length: A mendelian randomization study","volume":"15","author":"Zhu","year":"2023","journal-title":"Nutrients"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19586","article-title":"SGLT2 inhibition via empagliflozin improves endothelial function and reduces mitochondrial oxidative stress: insights from frail hypertensive and diabetic patients","volume":"79","author":"Mone","year":"2022","journal-title":"Hypertension"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.12088","article-title":"DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption","volume":"37","author":"Pipatpiboon","year":"2013","journal-title":"Eur J Neurosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585834\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:10:34Z","timestamp":1754021434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585834\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":39,"alternative-id":["10.3389\/fendo.2025.1585834"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1585834","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"1585834"}}